Sean Smolenyak, OD
Optometrist · Raleigh, NCNPI 1144275439
Payments from drug & device makers
Across 715 payments — averaging $716.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$144K
- AbbVie$127K
- Mallinckrodt Hospital Products Inc.$85K
- Alcon$43K
- Harrow Eye, LLC$34K
- Aerie Pharmaceuticals, Inc.$32K
- plus $47K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 136 | $144,330 |
| AbbVie(2 entities) | 164 | $126,710 |
| Mallinckrodt Hospital Products Inc. | 127 | $84,506 |
| Alcon | 79 | $43,331 |
| Harrow Eye, LLC | 32 | $34,461 |
| Aerie Pharmaceuticals, Inc. | 51 | $31,748 |
| Kala Pharmaceuticals, Inc. | 29 | $13,318 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 18 | $11,295 |
| Biotissue Holdings Inc. | 9 | $11,155 |
| Novartis | 8 | $3,913 |
| Alcon Research LLC | 2 | $3,250 |
| Glaukos Corporation | 12 | $2,592 |
| Tarsus Pharmaceuticals, Inc. | 11 | $308 |
| Bausch & Lomb Americas Inc. | 8 | $298 |
| Johnson & Johnson Vision Care, Inc. | 5 | $138 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $122 |
| Oyster Point Pharma, Inc. | 6 | $119 |
| Dompe US, Inc. | 4 | $108 |
| ANI Pharmaceuticals, Inc. | 3 | $80 |
| Coopervision Inc. | 1 | $74 |
| Apellis Pharmaceuticals, Inc. | 1 | $66 |
| Optos, Inc. | 1 | $65 |
| Lensar, Inc. | 1 | $45 |
| Notal Vision, Inc. | 1 | $38 |
| Ocular Therapeutix, Inc. | 2 | $26 |
| LKC Technologies, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
How this compares
$512,135 in reported general payments places this provider in the 95th percentile of 1,326 optometrist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in Raleigh
- Carol AuneRaleigh$1.7M
- Osama SaidRaleigh$597K
- Bianca OliverRaleigh$242K
- Paul ForsythRaleigh$56K
- Darryl GloverRaleigh$44K
- Balpreet SohiRaleigh$12K
- Kiarash BassiriRaleigh$11K
- Crystal BrimerWilmington$920K
- Ryan CorteAsheville$569K
- Sanjay PatelApex$518K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.